Entera Bio ENTX Estimates

NASDAQ ENTX
$2.69 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT
Analyst Estimates

Entera Bio Ltd. Revenue Estimates

Periods 26
Next Period Q4 24
Consensus 41,701.60

Analysts expect Entera Bio Ltd. to report revenue of 41,701.60 for Q4 24, against a range of 37,918.22 to 45,484.98. The most recent reported quarter, Q2 26, came in at 0.00.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) 42,000.00--42,000.00--0.000.000.00-----
High Estimate 44,012.6945,484.980.000.000.000.000.000.000.000.000.000.00-3,850.12
Low Estimate 38,161.7137,918.220.000.000.000.000.000.000.000.000.000.00-4,668.20
Consensus Estimate 41,087.2041,701.600.000.000.000.000.000.000.000.000.000.00-4,259.16
Analyst Estimates

Entera Bio Ltd. Earnings Per Share (EPS) Estimates

Periods 26
Next Period Q3 26
Consensus -0.07

Analysts expect Entera Bio Ltd. to report earnings per share of -0.07 for Q3 26, against a range of -0.07 to -0.07. The most recent reported quarter, Q2 26, came in at -0.14, a 75.0% miss against the -0.08 consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) -0.08-0.06-0.06-0.06-0.07-0.06-0.07-0.14--------
High Estimate -0.05-0.07-0.07-0.09-0.09-0.09-0.08-0.08-0.07-0.14-0.11-0.11-0.08-0.13-0.10-0.11
Low Estimate -0.05-0.09-0.07-0.11-0.09-0.09-0.08-0.08-0.07-0.16-0.11-0.13-0.08-0.13-0.12-0.11
Consensus Estimate -0.05-0.08-0.07-0.10-0.09-0.09-0.08-0.08-0.07-0.15-0.11-0.12-0.08-0.13-0.11-0.11

Entera Bio Ltd. Estimates API

Pull Wall Street consensus for Entera Bio Ltd. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/estimates?ticker=ENTX&mode=revenue&api_key=YOUR_API_KEY